Yacca Pharmaceuticals Private Limited, a active private limited company, was established on 11 December 1989 in Uttar Pradesh, Uttar Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231UP1989PTC011458. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 31 professional, Its leadership includes Anjali Bansal (Director), Pankaj Kumar Bansal (Managing Director), Aayush Mohan Bansal (Director). It holds ₹49.02 Cr open charges and ₹4.48 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 220/1Hirapur Siyana Road Bulandshahr, Uttar Pradesh, Uttar Pradesh, 203001.
U24231UP1989PTC011458
011458
11 December 1989
₹1.50 M
₹1.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Yacca Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anjali Bansal | Director | 11 Dec 1989 | Current |
| Pankaj Kumar Bansal | Managing Director | 11 Dec 1989 | Current |
| Aayush Mohan Bansal | Director | 11 Aug 2018 | Current |
| Prateek Mohan Bansal | Director | 11 Aug 2018 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Yacca Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.62% increase. The company also saw a substantial improvement in profitability, with a 15.09% increase in profit. The company's net worth moved up by a moderate rise of 5.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Yacca Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹490,170,200.00
₹44,755,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Sep 2022 | Others | ₹29.99 Cr | Open |
| 16 Sep 2020 | Hdfc Bank Limited | ₹18.93 Cr | Open |
| 16 May 1994 | Pankaj K. Bansal | ₹1.00 M | Open |
| 27 Nov 2019 | Others | ₹2.38 Cr | Satisfied |
| 02 Jan 2016 | Hdfc Bank Limited | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Yacca Pharmaceuticals has a workforce of 31 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Yacca Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yacca Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited of Rs. 189.32 M registered on 16 Sep 2020 with Charge ID 100388330 was modified on 06 Jun 2025. was recorded as a recent event.
Progress on A charge with Others of Rs. 299.85 M registered on 06 Sep 2022 with Charge ID 100612073 was modified on 29 Jan 2025. was documented.
The activity Yacca Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Yacca Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
A charge with Others amounted to Rs. 299.85 M with Charge ID 100612073 was registered on 06 Sep 2022. was recorded as a recent event.
A charge registered on 27 Nov 2019 via Charge ID 100305438 with Others was fully satisfied on 12 Jan 2021. was recorded as a recent event.
The CIN of Yacca Pharmaceuticals Private Limited is U24231UP1989PTC011458.
Yacca Pharmaceuticals Private Limited is headquartered at 220/1Hirapur Siyana Road Bulandshahr, Uttar Pradesh, Uttar Pradesh, 203001.
Yacca Pharmaceuticals Private Limited was incorporated on 11 December 1989.
The current directors of Yacca Pharmaceuticals Private Limited are
The primary industry of Yacca Pharmaceuticals Private Limited is Manufacturing.
Yacca Pharmaceuticals Private Limited is unlisted.
The authorized capital of Yacca Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.00 M.
The compliance status of Yacca Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX